Precipio, Inc. earnings releases PRPO

Precipio, Inc. last reported quarterly results on Aug 14, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $7.0 million (+24.7% year over year) and diluted EPS of -$0.12. It usually reports 45–59 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 27, 2026.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 45–59 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Aug 14, 2026
45 days after quarter end
Q2 FY2026
ended Jun 30, 2026
7
+24.7%
-0
-0.12
-340.0%
Feb 27, 2026
58 days after quarter end
Q4 FY2025
ended Dec 31, 2025
7
+28.4%
—
—
May 15, 2025
45 days after quarter end
Q1 FY2025
ended Mar 31, 2025
5
—
-0.59
Feb 28, 2022
59 days after quarter end
—
ended Dec 31, 2021
—
—
—
Jul 28, 2021
28 days after quarter end
—
ended Jun 30, 2021
—
—
—
Jul 22, 2020
22 days after quarter end
—
ended Jun 30, 2020
—
—
—
Feb 14, 2019
45 days after quarter end
—
ended Dec 31, 2018
—
—
—
Oct 16, 2018
16 days after quarter end
—
ended Sep 30, 2018
—
—
—

Company profile

Industry
Laboratory Analytical Instruments (SIC 3826)
Listed as
PRPO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New Haven, CT
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1043961
Former names
TRANSGENOMIC INC (until Jun 30, 2017)

Other Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.